ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma
Gespeichert in:
| Veröffentlicht in: | Annals of surgical oncology 2022-04, Vol.29 (4), p.2406-2406 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2406 |
|---|---|
| container_issue | 4 |
| container_start_page | 2406 |
| container_title | Annals of surgical oncology |
| container_volume | 29 |
| creator | Matsuyama, Ryusei Mori, Ryutaro Ota, Yohei Homma, Yuki Yabusita, Yasuhiro Hiratani, Seigo Murakami, Takashi Sawada, Yu Miyake, Kentaro Shimizu, Yasuhiro Kumamoto, Takafumi Endo, Itaru |
| description | |
| doi_str_mv | 10.1245/s10434-021-11285-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2640559426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2640559426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-ef09ae2caf77f39b7b6acb0becc4c2c3ecd2eb1689e1bcb17e93f6494976aa113</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EoqXwAhyQJc4pHttxYm7LCkqliiIKXK2xd9LNKokXO0HqsW9ely3lxmksz_f_I32MvQZxClLX7zIIrXQlJFQAsq0r9YQdQ12-tGnhaXkL01ZWmvqIvch5JwQ0StTP2ZHStgVZi2N2u7q65D_7vODAVz7PCcP8np-P-zJ57PgZjaGf0fcT8a_DkvkV8C8UcbNbfuM08_WWxjhvKeH-hseJf4hpQ2m4x79RplCiQ0lS6rf9gKnwccDpuo8BU-inOOJL9qzDIdOrh3nCfnz6-H39ubq4PDtfry6qIE0zV9QJiyQDdk3TKesbbzB44SkEHWRQFDaSPJjWEvjgoSGrOqOtto1BBFAn7O2hd5_ir4Xy7HZxSVM56aTRoq6tlqZQ8kCFFHNO1Ll96kdMNw6Eu7fuDtZdse7-WHeqhN48VC9-pM1j5K_mAqgDkMtquqb07_Z_au8Aod2PcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2640559426</pqid></control><display><type>article</type><title>ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei ; Homma, Yuki ; Yabusita, Yasuhiro ; Hiratani, Seigo ; Murakami, Takashi ; Sawada, Yu ; Miyake, Kentaro ; Shimizu, Yasuhiro ; Kumamoto, Takafumi ; Endo, Itaru</creator><creatorcontrib>Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei ; Homma, Yuki ; Yabusita, Yasuhiro ; Hiratani, Seigo ; Murakami, Takashi ; Sawada, Yu ; Miyake, Kentaro ; Shimizu, Yasuhiro ; Kumamoto, Takafumi ; Endo, Itaru</creatorcontrib><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-021-11285-3</identifier><identifier>PMID: 34981250</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; ASO Visual Abstract ; Bile Duct Neoplasms - drug therapy ; Bile Duct Neoplasms - pathology ; Bile Duct Neoplasms - surgery ; Chemotherapy ; Cholangiocarcinoma ; Cholangiocarcinoma - drug therapy ; Cholangiocarcinoma - surgery ; Deoxycytidine - analogs & derivatives ; Deoxycytidine - therapeutic use ; Gemcitabine ; Humans ; Klatskin Tumor - pathology ; Medicine ; Medicine & Public Health ; Neoadjuvant Therapy ; Oncology ; Pancreatic Neoplasms - drug therapy ; Surgery ; Surgical Oncology ; Treatment Outcome</subject><ispartof>Annals of surgical oncology, 2022-04, Vol.29 (4), p.2406-2406</ispartof><rights>Society of Surgical Oncology 2022</rights><rights>Society of Surgical Oncology 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-021-11285-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-021-11285-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34981250$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsuyama, Ryusei</creatorcontrib><creatorcontrib>Mori, Ryutaro</creatorcontrib><creatorcontrib>Ota, Yohei</creatorcontrib><creatorcontrib>Homma, Yuki</creatorcontrib><creatorcontrib>Yabusita, Yasuhiro</creatorcontrib><creatorcontrib>Hiratani, Seigo</creatorcontrib><creatorcontrib>Murakami, Takashi</creatorcontrib><creatorcontrib>Sawada, Yu</creatorcontrib><creatorcontrib>Miyake, Kentaro</creatorcontrib><creatorcontrib>Shimizu, Yasuhiro</creatorcontrib><creatorcontrib>Kumamoto, Takafumi</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><title>ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>ASO Visual Abstract</subject><subject>Bile Duct Neoplasms - drug therapy</subject><subject>Bile Duct Neoplasms - pathology</subject><subject>Bile Duct Neoplasms - surgery</subject><subject>Chemotherapy</subject><subject>Cholangiocarcinoma</subject><subject>Cholangiocarcinoma - drug therapy</subject><subject>Cholangiocarcinoma - surgery</subject><subject>Deoxycytidine - analogs & derivatives</subject><subject>Deoxycytidine - therapeutic use</subject><subject>Gemcitabine</subject><subject>Humans</subject><subject>Klatskin Tumor - pathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoadjuvant Therapy</subject><subject>Oncology</subject><subject>Pancreatic Neoplasms - drug therapy</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Treatment Outcome</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kMFu1DAQhi0EoqXwAhyQJc4pHttxYm7LCkqliiIKXK2xd9LNKokXO0HqsW9ely3lxmksz_f_I32MvQZxClLX7zIIrXQlJFQAsq0r9YQdQ12-tGnhaXkL01ZWmvqIvch5JwQ0StTP2ZHStgVZi2N2u7q65D_7vODAVz7PCcP8np-P-zJ57PgZjaGf0fcT8a_DkvkV8C8UcbNbfuM08_WWxjhvKeH-hseJf4hpQ2m4x79RplCiQ0lS6rf9gKnwccDpuo8BU-inOOJL9qzDIdOrh3nCfnz6-H39ubq4PDtfry6qIE0zV9QJiyQDdk3TKesbbzB44SkEHWRQFDaSPJjWEvjgoSGrOqOtto1BBFAn7O2hd5_ir4Xy7HZxSVM56aTRoq6tlqZQ8kCFFHNO1Ll96kdMNw6Eu7fuDtZdse7-WHeqhN48VC9-pM1j5K_mAqgDkMtquqb07_Z_au8Aod2PcQ</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Matsuyama, Ryusei</creator><creator>Mori, Ryutaro</creator><creator>Ota, Yohei</creator><creator>Homma, Yuki</creator><creator>Yabusita, Yasuhiro</creator><creator>Hiratani, Seigo</creator><creator>Murakami, Takashi</creator><creator>Sawada, Yu</creator><creator>Miyake, Kentaro</creator><creator>Shimizu, Yasuhiro</creator><creator>Kumamoto, Takafumi</creator><creator>Endo, Itaru</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>202204</creationdate><title>ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma</title><author>Matsuyama, Ryusei ; Mori, Ryutaro ; Ota, Yohei ; Homma, Yuki ; Yabusita, Yasuhiro ; Hiratani, Seigo ; Murakami, Takashi ; Sawada, Yu ; Miyake, Kentaro ; Shimizu, Yasuhiro ; Kumamoto, Takafumi ; Endo, Itaru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-ef09ae2caf77f39b7b6acb0becc4c2c3ecd2eb1689e1bcb17e93f6494976aa113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>ASO Visual Abstract</topic><topic>Bile Duct Neoplasms - drug therapy</topic><topic>Bile Duct Neoplasms - pathology</topic><topic>Bile Duct Neoplasms - surgery</topic><topic>Chemotherapy</topic><topic>Cholangiocarcinoma</topic><topic>Cholangiocarcinoma - drug therapy</topic><topic>Cholangiocarcinoma - surgery</topic><topic>Deoxycytidine - analogs & derivatives</topic><topic>Deoxycytidine - therapeutic use</topic><topic>Gemcitabine</topic><topic>Humans</topic><topic>Klatskin Tumor - pathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoadjuvant Therapy</topic><topic>Oncology</topic><topic>Pancreatic Neoplasms - drug therapy</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsuyama, Ryusei</creatorcontrib><creatorcontrib>Mori, Ryutaro</creatorcontrib><creatorcontrib>Ota, Yohei</creatorcontrib><creatorcontrib>Homma, Yuki</creatorcontrib><creatorcontrib>Yabusita, Yasuhiro</creatorcontrib><creatorcontrib>Hiratani, Seigo</creatorcontrib><creatorcontrib>Murakami, Takashi</creatorcontrib><creatorcontrib>Sawada, Yu</creatorcontrib><creatorcontrib>Miyake, Kentaro</creatorcontrib><creatorcontrib>Shimizu, Yasuhiro</creatorcontrib><creatorcontrib>Kumamoto, Takafumi</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsuyama, Ryusei</au><au>Mori, Ryutaro</au><au>Ota, Yohei</au><au>Homma, Yuki</au><au>Yabusita, Yasuhiro</au><au>Hiratani, Seigo</au><au>Murakami, Takashi</au><au>Sawada, Yu</au><au>Miyake, Kentaro</au><au>Shimizu, Yasuhiro</au><au>Kumamoto, Takafumi</au><au>Endo, Itaru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2022-04</date><risdate>2022</risdate><volume>29</volume><issue>4</issue><spage>2406</spage><epage>2406</epage><pages>2406-2406</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34981250</pmid><doi>10.1245/s10434-021-11285-3</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1068-9265 |
| ispartof | Annals of surgical oncology, 2022-04, Vol.29 (4), p.2406-2406 |
| issn | 1068-9265 1534-4681 |
| language | eng |
| recordid | cdi_proquest_journals_2640559426 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use ASO Visual Abstract Bile Duct Neoplasms - drug therapy Bile Duct Neoplasms - pathology Bile Duct Neoplasms - surgery Chemotherapy Cholangiocarcinoma Cholangiocarcinoma - drug therapy Cholangiocarcinoma - surgery Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Gemcitabine Humans Klatskin Tumor - pathology Medicine Medicine & Public Health Neoadjuvant Therapy Oncology Pancreatic Neoplasms - drug therapy Surgery Surgical Oncology Treatment Outcome |
| title | ASO Visual Abstract: Impact of Gemcitabine Plus S1 Neoadjuvant Chemotherapy on Borderline Resectable Perihilar Cholangiocarcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A20%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ASO%20Visual%20Abstract:%20Impact%20of%20Gemcitabine%20Plus%20S1%20Neoadjuvant%20Chemotherapy%20on%20Borderline%20Resectable%20Perihilar%20Cholangiocarcinoma&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Matsuyama,%20Ryusei&rft.date=2022-04&rft.volume=29&rft.issue=4&rft.spage=2406&rft.epage=2406&rft.pages=2406-2406&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-021-11285-3&rft_dat=%3Cproquest_cross%3E2640559426%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2640559426&rft_id=info:pmid/34981250&rfr_iscdi=true |